Navigation Links
Duke stem cell biologist wins 3 major awards in 1 month
Date:9/22/2008

DURHAM, N.C. Chay Kuo, M.D., Ph.D., assistant professor of cell biology at Duke University Medical Center, has won three prestigious awards in one fell swoop. His cutting-edge, noteworthy progress in stem cell research is the reason that three different organizations called him with good news this month.

"Chay is a remarkable physician-scientist whose work reveals secrets of neural stem cells, offering hope for children born with brain injuries," said Duke School of Medicine Dean Nancy C. Andrews.

"The Cell Biology Department is very proud of Chay and his achievements," said Brigid Hogan, Ph.D., chair of the Duke Department of Cell Biology. "He is a wonderful example of how scientists doing basic research at Duke are working hard to build bridges to clinicians dealing with the most heartbreaking medical problems. The innovative ideas of our young faculty like Chay, in combination with the most advanced technologies for real-time imaging and chemical screening, are pushing the envelope of discovery research at Duke."

"My job as a scientist is to tackle difficult questions and see how they will advance the field of neurological disease research in the coming years, and these awards will give me the resources to explore promising avenues and advance findings more quickly," said Dr. Kuo. "The awards are unexpected developments for my new laboratory and the dedicated young people who have joined me. None of this would have been possible without the generous support of the Jean and George Brumley, Jr., Neonatal and Perinatal Research Institute, the Tisch Cancer Investigators Program, and the Duke Stem Cell and Regenerative Medicine program.

He heard from the National Institutes of Health that he won the Director's New Innovator Award of $1.5 million over five years. This award is for work on neural stem cells and their role in brain injury and repair. "The goal of this award is to encourage scientists to do exactly what they want to do," Kuo said. "One thing I have always wanted to do is science that could lead to therapeutic solutions for patients suffering from brain injuries after trauma and stroke."

The NIH award goes to "highly creative researchers (who) are tackling important scientific challenges with bold ideas and inventive technologies that promise to break through barriers and radically shift our understanding," said NIH Director Elias A. Zerhouni, M.D., who will announce the awards on Sept. 22.

Kuo also won a Distinguished Scientist Award from the Sontag Foundation for his research into brain tumor development. This prestigious award is $600,000 over a four-year period, beginning October 1, 2008. "Stem cells hold tremendous therapeutic promise, but stem cells behaving badly can have grave consequences," said Kuo. Tumors in the brain are often deadly, but where these tumor cells come from is poorly understood. Kuo and colleagues are planning experiments to investigate how mutations in neural stem cells can give rise to brain tumors, and how destroying these cancer-causing stem cells may result in successful therapy. Only two Sontag Distinguished Scientist Awards were given this year.

"These awards reflect the vibrant and exciting atmosphere at Duke as a place to conduct the best stem cell research, both to realize the potential for therapy and as a target for cancer treatments," Kuo said.

Third, Kuo received a Packard Fellow in Science and Engineering Award from the David and Lucile Packard Foundation. Aimed at supporting unusually creative researchers early in their careers, the fellowship provides $875,000 over five years. With these funds, the Kuo laboratory and collaborators will engineer a chemical screening platform that will give scientists powerful new tools to understand the architectural blueprints of how stem cell environments are constructed, "which will give us new ways to look at biological problems," Kuo said. "This award will provide a basis for and tie together our future work."


'/>"/>

Contact: Mary Jane Gore
mary.gore@duke.edu
919-660-1309
Duke University Medical Center
Source:Eurekalert

Related biology news :

1. The American Society of Plant Biologists announces 2007 awards
2. UCR plant cell biologist to study how plant stem cells maintain and change their identity
3. Biologists expose hidden costs of firefly flashes
4. Tufts University biologists link Huntingtons disease to health benefits in young
5. UC Riverside biologist receives prestigious MacArthur Fellowship
6. University biologist publishes book on bird speciation
7. UD plant biologists uncover top wetland plants hidden weapon
8. Evolution is deterministic, not random, biologists conclude from multi-species study
9. Biologists find unusual plant gene: abstinence by mutual consent
10. UAB microbiologist wins top Czech science honor
11. Ant parasite turns host into ripe red berry, biologists discover
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/13/2016)...  IMPOWER physicians supporting Medicaid patients in ... standard in telehealth thanks to a new partnership with ... IMPOWER patients can routinely track key health measurements, such ... and, when they opt in, share them with IMPOWER ... local retail location at no cost. By leveraging this ...
(Date:3/31/2016)...  Genomics firm Nabsys has completed a financial  restructuring ... , M.D., who returned to the company in October ... team, including Chief Technology Officer, John Oliver , ... and Vice President of Software and Informatics, Michael ... Dr. Bready served as CEO of Nabsys from 2005-2014 ...
(Date:3/23/2016)... 23, 2016 ... Gesichts- und Stimmerkennung mit Passwörtern     ... MESG ), ein führender Anbieter digitaler ... mit SpeechPro zusammenarbeitet, um erstmals dessen Biometrietechnologie ... die Möglichkeit angeboten, im Rahmen mobiler Apps ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... 2016 , ... While the majority of commercial spectrophotometers and fluorometers use the ... models are higher end machines that use the more unconventional z-dimension of 20mm. ... the bottom of the cuvette holder. , FireflySci has developed several Agilent flow ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge ... envision new ways to harness living systems and biotechnology, ... Art (MoMA) in New York City ... 130 participating students, showcased projects at MoMA,s Celeste Bartos ... Paola Antonelli , MoMA,s senior curator of architecture and ...
(Date:6/23/2016)... , June 23, 2016 Apellis ... Phase 1 clinical trials of its complement C3 ... single and multiple ascending dose studies designed to ... (PD) of subcutaneous injection in healthy adult volunteers. ... (SC) either as a single dose (ranging from ...
Breaking Biology Technology: